Oncology Practices May Be Hurt by Medicare Drug Price Negotiations

The U.S. Department of Health and Human Services (HHS) is set to negotiate with drug manufacturers o...

Oncologists Fight “Ludicrous” Restriction, as PBMs Complicate Issue

When the COVID-19 public health emergency expired, it ended a key exemption that meant that communit...

Policy Change Puts Dollars Behind Patient Navigation in Oncology

Editor’s Note: This is part of an ongoing series designed for oncologists to share their opinions on...